Resampling methods are introduced for the construction of confidence i
ntervals for treatment effects associated with the primary and seconda
ry endpoints of a clinical trial whose stopping rule is specified by a
group sequential test. These methods are nonparametric and compare fa
vourably with the exact methods that assume the responses to be normal
ly distributed.